Skip to content
Screener

LeMaitre Vascular LMAT Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$64.5MBeat by $1.6M
EPS$0.68Beat by $0.01
Revenue estimate$62.8M
EPS estimate$0.67

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.4M
EPS estimate$0.69

Financials

Q4 2025

Income statement

See full
Revenue$64.5M+15.7%
Gross profit$46.2M+19.7%
Operating income$18.8M+46.5%
Net income$15.6M+39.3%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$28.2M+10.3%
Total debt$16.9M-5.4%
Total equity$393.5M+16.7%
Total assets$615.7M+11.6%

Cash flow

See full
Operating cash flow$23.2M+52.5%
CapEx$1.8M-13.1%
Free cash flow$21.4M+62.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.84B-11.2%
Enterprise value$1.83B-11.4%
P/E31.9×-15.2×
P/S7.4×-2.1×

Profitability

See full
Gross margin71.5%+2.9pp
Operating margin27.2%+3.4pp
Net margin23.1%+3.1pp
FCF margin29.8%+12.9pp

Returns & leverage

See full
Return on equity15.8%+1.9pp
Debt / equity0×0.0×
Current ratio12.9×-0.2×

FAQ

When did LeMaitre Vascular report Q4 2025 earnings?
LeMaitre Vascular (LMAT) reported Q4 2025 earnings on February 25, 2026 after market close.
What were LeMaitre Vascular's Q4 2025 revenue and EPS?
LeMaitre Vascular reported revenue of $64.5M and eps of $0.68 for Q4 2025.
Did LeMaitre Vascular beat estimates in Q4 2025?
Revenue beat the consensus estimate of $62.8M by $1.6M. EPS beat the consensus estimate of $0.67 by $0.01.
How did LeMaitre Vascular's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.7% from $55.7M a year earlier and eps grew 38.8% from $0.49.
Where can I find LeMaitre Vascular's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-071954) and the 10-K periodic report (0001193125-26-073360) directly on SEC EDGAR. The filing index links above go to sec.gov.